Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanxia Wang

Showing results (351-360 of 356) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 356 results.
Frontiers in Immunology|July 11, 2022
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 TrialShengli Xia, Kai Duan, Yuntao Zhang, et al.
The Lancet. Infectious Diseases|September 18, 2021
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trialShengLi Xia, YunTao Zhang, YanXia Wang, et al.
Cell Discovery|January 7, 2023
Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5Yanqun Wang, An Yan, Deyong Song, et al.
Eclinicalmedicine|July 12, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trialWanshen Guo, Kai Duan, Yuntao Zhang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 24, 2012
A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patientsCai-Hong Zeng, Weibo Le, Zhaohui Ni, et al.
Innovation (Cambridge (Mass.))|December 12, 2022
Immune response and homeostasis mechanism following administration of BBIBP-CorV SARS-CoV-2 inactivated vaccineJianhua Yin, Yingze Zhao, Fubaoqian Huang, et al.
Pageof 36

Showing results (351-360 of 356) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 356 results.
Frontiers in Immunology|July 11, 2022
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 TrialShengli Xia, Kai Duan, Yuntao Zhang, et al.
The Lancet. Infectious Diseases|September 18, 2021
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trialShengLi Xia, YunTao Zhang, YanXia Wang, et al.
Cell Discovery|January 7, 2023
Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5Yanqun Wang, An Yan, Deyong Song, et al.
Eclinicalmedicine|July 12, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trialWanshen Guo, Kai Duan, Yuntao Zhang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 24, 2012
A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patientsCai-Hong Zeng, Weibo Le, Zhaohui Ni, et al.
Innovation (Cambridge (Mass.))|December 12, 2022
Immune response and homeostasis mechanism following administration of BBIBP-CorV SARS-CoV-2 inactivated vaccineJianhua Yin, Yingze Zhao, Fubaoqian Huang, et al.
Pageof 36